Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze JAZZ stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate JAZZ investment potential.

What is JAZZ stock price today?

Get real-time JAZZ stock price, historical data, and price charts on Financhill. Track JAZZ performance with our advanced analysis tools.

Is JAZZ a good investment?

Evaluate JAZZ investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy JAZZ stock?

To buy JAZZ stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of JAZZ?

View detailed market capitalization data and company valuation metrics for JAZZ on our comprehensive analysis page.

What is the P/E ratio of JAZZ?

Use our fundamental analysis tools to view JAZZ P/E ratio and compare valuation metrics with industry peers.

What are JAZZ earnings?

View JAZZ earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Jazz Pharmaceuticals Plc 10K Form

Buy

JAZZ
Jazz Pharmaceuticals Plc

Last Price:

$166.93

Seasonality Move:

8.99%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-02	10Q	JAZZ/Jazz Pharmaceuticals Plc Quarterly
2023-11-08	10Q	JAZZ/Jazz Pharmaceuticals Plc Quarterly
2023-08-09	10Q	JAZZ/Jazz Pharmaceuticals Plc Quarterly
2023-05-10	10Q	JAZZ/Jazz Pharmaceuticals Plc Quarterly
2022-11-09	10Q	JAZZ/Jazz Pharmaceuticals Plc Quarterly
2022-08-03	10Q	JAZZ/Jazz Pharmaceuticals Plc Quarterly

Receive JAZZ News And Ratings

See the #1 stock for the next 7 days that we like better than JAZZ

JAZZ Financial Statistics

Sales & Book Value

Annual Sales:	$4.1B
Cash Flow:	$429.4M
Price / Cash Flow:	7.96
Annual Sales:	$65.18
Price / Book:	2.56

Profitability

EPS (TTM):	-6.07010
Net Income (TTM):	$-368.5M
Gross Margin:	$3B
Return on Equity:	-9.16%
Return on Assets:	-3.17%

Jazz Pharmaceuticals Plc Earnings Forecast

Key Jazz Pharmaceuticals Plc Financial Ratios

The Gross Profit Margin over the past 21 years for JAZZ is 73.63%.
The Selling, General & Administrative Expenses for JAZZ have been equal to 34.05% of Gross Profit Margin.
The Research & Development expenses have been 21.73% of Revenue.
The Interest Expense is 60.63% of Operating Income.
The Net Earning history of JAZZ is 13.77% of Total Revenues.
Per Share Earnings over the last 21 years have been positive in 13 years.

Jazz Pharmaceuticals Plc Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Pharmaceuticals
Sector:	Health Care
Current Symbol:	JAZZ
CUSIP:	G50871
Website:	jazzpharma.com

Debt

Debt-to-Equity Ratio:	1.37
Current Ratio:	1.65
Quick Ratio:	1.24

Price-to-Earnings

Trailing P/E Ratio:	19.32
Forward P/E Ratio:	7.36

JAZZ Technical Analysis vs Fundamental Analysis

Buy

Jazz Pharmaceuticals Plc (JAZZ) is a Buy

Is Jazz Pharmaceuticals Plc a Buy or a Sell?

Jazz Pharmaceuticals Plc stock is rated a Buy

The current Jazz Pharmaceuticals Plc [JAZZ] share price is $167.10. The Score for JAZZ is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.